LIGAND PHARMACEUTICALS INCORPORATED: net_income
| Value | {"amount": 9715000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-12-31 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/93d08c94-d29b-4637-bbd7-42b5be1cd2b7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-470008Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/net-income/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/93d08c94-d29b-4637-bbd7-42b5be1cd2b7
History
- supersedes {"amount": 10176000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001193125-12-075655)